TY - JOUR
T1 - Integrin β4 signaling promotes tumor angiogenesis
AU - Nikolopoulos, Sotiris N.
AU - Blaikie, Pamela
AU - Yoshioka, Toshiaki
AU - Guo, Wenjun
AU - Giancotti, Filippo G.
N1 - Funding Information:
We thank K. Owaribe, R. Timple, and H. Gardner for reagents; the Transgenic and Knockout Mouse Facility and the Molecular Cytology Facility of the Memorial Sloan-Kettering Cancer Center (MSKCC) for help; and M. Dans, S. Klein, D. Lyden, and A. Petridis for help and discussions. This work was supported by NIH awards F32 CA97886 (to S.N.N.), R37 CA58976 (to F.G.G.), and P30 CA08748 (to MSKCC).
PY - 2004/11
Y1 - 2004/11
N2 - Mice carrying a targeted deletion of the signaling portion of the integrin β4 subunit display drastically reduced angiogenesis in response to bFGF in the Matrigel plug assay and to hypoxia in the retinal neovascularization model. Molecular cytology indicates that α6β4 signaling promotes branching of β4+ medium- and small-size vessels into β4- microvessels without exerting a direct effect on endothelial cell proliferation or survival. Signaling studies reveal that α6β4 signaling induces endothelial cell migration and invasion by promoting nuclear translocation of P-ERK and NF-κB. Upon subcutaneous implantation of various cancer cells, the mutant mice develop smaller and significantly less vascularized tumors than wild-type controls. These results provide genetic evidence that α6β4 signaling promotes the onset of the invasive phase of pathological angiogenesis and hence identify a novel target for antiangiogenic therapy.
AB - Mice carrying a targeted deletion of the signaling portion of the integrin β4 subunit display drastically reduced angiogenesis in response to bFGF in the Matrigel plug assay and to hypoxia in the retinal neovascularization model. Molecular cytology indicates that α6β4 signaling promotes branching of β4+ medium- and small-size vessels into β4- microvessels without exerting a direct effect on endothelial cell proliferation or survival. Signaling studies reveal that α6β4 signaling induces endothelial cell migration and invasion by promoting nuclear translocation of P-ERK and NF-κB. Upon subcutaneous implantation of various cancer cells, the mutant mice develop smaller and significantly less vascularized tumors than wild-type controls. These results provide genetic evidence that α6β4 signaling promotes the onset of the invasive phase of pathological angiogenesis and hence identify a novel target for antiangiogenic therapy.
UR - http://www.scopus.com/inward/record.url?scp=7944224012&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=7944224012&partnerID=8YFLogxK
U2 - 10.1016/j.ccr.2004.09.029
DO - 10.1016/j.ccr.2004.09.029
M3 - Article
C2 - 15542431
AN - SCOPUS:7944224012
SN - 1535-6108
VL - 6
SP - 471
EP - 483
JO - Cancer Cell
JF - Cancer Cell
IS - 5
ER -